MedPath

The effect of XMM-HR2 rehabilitation for the patients with stroke.

Phase 3
Conditions
Stroke
Cerebrovascular disease
D020521
Registration Number
JPRN-jRCTs032200045
Lead Sponsor
Fujiwara Toshiyuki
Brief Summary

Both groups showed the some improvement of upper extremity and spasticity, whereas only active training group showed the improvement of hand function and finger spasticity.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
20
Inclusion Criteria

1. Hemiparesis patients based on stroke.
2. Age 20>= years and <80years
3. 60>= days from onset of stroke
4. SIAS finger function test is 2 or less and knee mouth test is 2 or more
5. Surface sense of upper extremity is scored 1 or more with SIAS
6. ROM of wrist is enough to wear the devise (XMM HR2)
7. Spasticity of paretic finger is 2 or less with modified Ashworth Scale
8. 2>= month from the last boturinum therapy, if patient received the boturinum therapy.
9. Patients who could come to outpatient clinic following to the study protocol.
10. Witten informed consent.

Exclusion Criteria

1. Severe cardiac disease
2. Uncontrolled hypertension
3. Acute illness and fever
4. Recent medical history of pulmonary embolism, acute cor pulmonale, and severe pulmonary hypertension
5. Severe liver failure and renal failure
6. Orthopedic complication, preventing exercise
7. Severe cognitive impairment and mental illness
8. Other metabolic disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fugel-Meyer Assessment upper extremity score
Secondary Outcome Measures
NameTimeMethod
Box and Block<br>Jebsen Taylor finger function test<br>Motor activity Log 14 <br>Modified Ashworth scale <br>SIAS finger function test<br>Reciprocal Inhibition in paretic upper extremity<br>Motor Evoked Potential by transcranial magnetic stimulation
© Copyright 2025. All Rights Reserved by MedPath